IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB

Irbesartan and Hydrochlorothiazide
$0.1592per EA

Strength

12.5; 150 mg/1; mg/1

NDC

33342005710

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202414

On Market Since

9/27/2012

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+3.9%

3M

-4.9%

6M

-3.4%

1Y

-5.2%

3Y

-20.4%

5Y

-42.4%

All

-51.2%